Q2 2018 Holdings
Filed 2018-08-14 | 51 holdings | $79.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.1M | 5,550,890 | 57.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $20.8M | 1,890,507 | 26.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $11.7M | 959,840 | 14.8% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $92.6K | 7,034,346 | 0.1% |
| Merus N V | COM | N5749R100 | $89.1K | 3,914,913 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $78.4K | 4,672,195 | 0.1% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $41.2K | 7,447,912 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $41.1K | 646,811 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $37.4K | 2,057,346 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $36.7K | 745,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $34.5K | 6,929,690 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $32.2K | 869,645 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $31.4K | 1,502,800 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $30.6K | 1,817,138 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $29.1K | 15,232,268 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $27.1K | 5,346,838 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $23.8K | 335,265 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $23.8K | 570,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $23.5K | 25,995,575 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $23.1K | 8,503,425 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $21.0K | 1,761,567 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $18.9K | 4,158,353 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $17.9K | 1,129,761 | 0.0% |
| Verastem Inc | COM | 92337C104 | $15.4K | 2,242,353 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $15.4K | 1,048,958 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $12.1K | 3,080,308 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $11.6K | 606,715 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $10.0K | 1,930,670 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.5K | 1,417,967 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $9.5K | 4,099,589 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $9.3K | 785,950 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $9.0K | 13,685,204 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.7K | 1,233,618 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $8.5K | 3,100,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $7.8K | 220,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $7.4K | 3,361,071 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $7.2K | 625,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.6K | 720,830 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $5.9K | 386,134 | 0.0% |
| Merrimack Pharmaceuticals Inc(MACKEUR) | COM NEW | 590328209 | $5.5K | 1,110,588 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $5.5K | 334,333 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.9K | 643,059 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $4.5K | 5,265,000 | 0.0% |
| Tocagen Inc | COM | 888846102 | $4.4K | 471,007 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $3.6K | 688,629 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $3.6K | 1,684,636 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.1K | 552,791 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $2.1K | 295,965 | 0.0% |
| Vical Inc | COM NEW | 925602203 | $1.5K | 1,332,605 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $709 | 4,089 | 0.0% |